Reaction
Metastases To Chest Wall reporting signals
As of the last recalculation, Metastases To Chest Wall appears in 342 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is EXEMESTANE (PRR 107.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Exemestane | 34 | 107.2 | 107.3 |
| Fulvestrant | 45 | 95.3 | 95.4 |
| Anastrozole Tablets | 28 | 86.4 | 86.5 |
| Letrozole Tablets | 54 | 80.9 | 81.0 |
| Letrozole | 63 | 76.1 | 76.2 |
| Anastrozole | 36 | 66.6 | 66.6 |
| Everolimus | 36 | 48.0 | 48.0 |
| Ribociclib | 22 | 45.3 | 45.3 |
| Ado-Trastuzumab Emtansine | 6 | 44.1 | 44.1 |
| Gefitinib | 6 | 41.2 | 41.2 |
| Alpelisib | 5 | 35.4 | 35.4 |
| Capecitabine | 46 | 35.2 | 35.2 |
| Gemcitabine Hydrochloride | 27 | 33.5 | 33.6 |
| Gemcitabine | 20 | 32.8 | 32.8 |
| Lapatinib | 8 | 32.1 | 32.1 |
| Trastuzumab | 31 | 30.1 | 30.1 |
| Doxorubicin Hydrochloride | 15 | 29.2 | 29.2 |
| Pertuzumab | 12 | 27.8 | 27.8 |
| Pazopanib Hydrochloride | 11 | 25.5 | 25.5 |
| Palbociclib | 28 | 19.4 | 19.4 |
| Olaparib | 5 | 14.7 | 14.8 |